scispace - formally typeset
P

Peter K. Lindenauer

Researcher at University of Massachusetts Medical School

Publications -  352
Citations -  13985

Peter K. Lindenauer is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Retrospective cohort study & Pneumonia. The author has an hindex of 55, co-authored 322 publications receiving 12278 citations. Previous affiliations of Peter K. Lindenauer include Miriam Hospital & The Joint Commission.

Papers
More filters
Journal ArticleDOI

Public Reporting and Pay for Performance in Hospital Quality Improvement

TL;DR: Hospitals engaged in both public reporting and pay for performance achieved modestly greater improvements in quality than did hospitals engaged only in public reporting.
Journal ArticleDOI

Perioperative beta-blocker therapy and mortality after major noncardiac surgery.

TL;DR: Perioperative beta-blocker therapy is associated with a reduced risk of in-hospital death among high-risk, but not low- risk, patients undergoing major noncardiac surgery and patient safety may be enhanced by increasing the use of Beta-blockers in high- risk patients.
Journal ArticleDOI

Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.

TL;DR: The increase in the number of hospitalizations for severe sepsis coupled with declining in-hospital mortality and declining geometric mean cost per case may reflect improvements in care or increases in discharges to skilled nursing facilities; however, these findings more likely represent changes in documentation and hospital coding practices that could bias efforts to conduct national surveillance.
Journal ArticleDOI

Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.

TL;DR: Treatment with lipid-lowering agents may reduce risk of death following major noncardiac surgery and clinical trials are required to confirm this observation.
Journal ArticleDOI

Perioperative beta-blocker therapy and mortality after major noncardiac surgery

TL;DR: Perioperative beta-blocker therapy is associated with a reduced risk of in-hospital death among high- risk, but not low-risk, patients undergoing major noncardiac surgery and patient safety may be enhanced by increasing the use of beta- blockers in high-risk patients.